Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 29 entries
Sorted by: Best Match Show Resources per page
Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer.

Nature biotechnology

Ouspenskaia T, Law T, Clauser KR, Klaeger S, Sarkizova S, Aguet F, Li B, Christian E, Knisbacher BA, Le PM, Hartigan CR, Keshishian H, Apffel A, Oliveira G, Zhang W, Chen S, Chow YT, Ji Z, Jungreis I, Shukla SA, Justesen S, Bachireddy P, Kellis M, Getz G, Hacohen N, Keskin DB, Carr SA, Wu CJ, Regev A.
PMID: 34663921
Nat Biotechnol. 2021 Oct 18; doi: 10.1038/s41587-021-01021-3. Epub 2021 Oct 18.

Tumor-associated epitopes presented on MHC-I that can activate the immune system against cancer cells are typically identified from annotated protein-coding regions of the genome, but whether peptides originating from novel or unannotated open reading frames (nuORFs) can contribute to...

Cite
Ouspenskaia T, Law T, Clauser KR, et al. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nat Biotechnol. 2021;doi: 10.1038/s41587-021-01021-3.
Ouspenskaia, T., Law, T., Clauser, K. R., Klaeger, S., Sarkizova, S., Aguet, F., Li, B., Christian, E., Knisbacher, B. A., Le, P. M., Hartigan, C. R., Keshishian, H., Apffel, A., Oliveira, G., Zhang, W., Chen, S., Chow, Y. T., Ji, Z., Jungreis, I., Shukla, S. A., Justesen, S., Bachireddy, P., Kellis, M., Getz, G., Hacohen, N., Keskin, D. B., Carr, S. A., Wu, C. J., & Regev, A. (2021). Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nature biotechnology, . https://doi.org/10.1038/s41587-021-01021-3
Ouspenskaia, Tamara, et al. "Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer." Nature biotechnology vol. (2021). doi: https://doi.org/10.1038/s41587-021-01021-3
Ouspenskaia T, Law T, Clauser KR, Klaeger S, Sarkizova S, Aguet F, Li B, Christian E, Knisbacher BA, Le PM, Hartigan CR, Keshishian H, Apffel A, Oliveira G, Zhang W, Chen S, Chow YT, Ji Z, Jungreis I, Shukla SA, Justesen S, Bachireddy P, Kellis M, Getz G, Hacohen N, Keskin DB, Carr SA, Wu CJ, Regev A. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nat Biotechnol. 2021 Oct 18; doi: 10.1038/s41587-021-01021-3. Epub 2021 Oct 18. PMID: 34663921.
Copy Download .nbib Format: NLM
SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs.

bioRxiv : the preprint server for biology

Weingarten-Gabbay S, Klaeger S, Sarkizova S, Pearlman LR, Chen DY, Bauer MR, Taylor HB, Conway HL, Tomkins-Tinch CH, Finkel Y, Nachshon A, Gentili M, Rivera KD, Keskin DB, Rice CM, Clauser KR, Hacohen N, Carr SA, Abelin JG, Saeed M, Sabeti PC.
PMID: 33024965
bioRxiv. 2020 Oct 26; doi: 10.1101/2020.10.02.324145.

T cell-mediated immunity may play a critical role in controlling and establishing protective immunity against SARS-CoV-2 infection; yet the repertoire of viral epitopes responsible for T cell response activation remains mostly unknown. Identification of viral peptides presented on class...

Cite
Weingarten-Gabbay S, Klaeger S, Sarkizova S, et al. SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs. bioRxiv. 2020;doi: 10.1101/2020.10.02.324145.
Weingarten-Gabbay, S., Klaeger, S., Sarkizova, S., Pearlman, L. R., Chen, D. Y., Bauer, M. R., Taylor, H. B., Conway, H. L., Tomkins-Tinch, C. H., Finkel, Y., Nachshon, A., Gentili, M., Rivera, K. D., Keskin, D. B., Rice, C. M., Clauser, K. R., Hacohen, N., Carr, S. A., Abelin, J. G., Saeed, M., & Sabeti, P. C. (2020). SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2020.10.02.324145
Weingarten-Gabbay, Shira, et al. "SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs." bioRxiv : the preprint server for biology vol. (2020). doi: https://doi.org/10.1101/2020.10.02.324145
Weingarten-Gabbay S, Klaeger S, Sarkizova S, Pearlman LR, Chen DY, Bauer MR, Taylor HB, Conway HL, Tomkins-Tinch CH, Finkel Y, Nachshon A, Gentili M, Rivera KD, Keskin DB, Rice CM, Clauser KR, Hacohen N, Carr SA, Abelin JG, Saeed M, Sabeti PC. SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs. bioRxiv. 2020 Oct 26; doi: 10.1101/2020.10.02.324145. PMID: 33024965; PMCID: PMC7536868.
Copy Download .nbib Format: NLM
Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias.

Nature immunology

Raundhal M, Ghosh S, Myers SA, Cuoco MS, Singer M, Carr SA, Waikar SS, Bonventre JV, Ritz J, Stone RM, Steensma DP, Regev A, Glimcher LH.
PMID: 34522041
Nat Immunol. 2021 Nov;22(11):1465. doi: 10.1038/s41590-021-01031-y.

No abstract available.

Cite
Raundhal M, Ghosh S, Myers SA, et al. Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias. Nat Immunol. 2021;22(11):1465doi: 10.1038/s41590-021-01031-y.
Raundhal, M., Ghosh, S., Myers, S. A., Cuoco, M. S., Singer, M., Carr, S. A., Waikar, S. S., Bonventre, J. V., Ritz, J., Stone, R. M., Steensma, D. P., Regev, A., & Glimcher, L. H. (2021). Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias. Nature immunology, 22(11), 1465. https://doi.org/10.1038/s41590-021-01031-y
Raundhal, Mahesh, et al. "Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias." Nature immunology vol. 22,11 (2021): 1465. doi: https://doi.org/10.1038/s41590-021-01031-y
Raundhal M, Ghosh S, Myers SA, Cuoco MS, Singer M, Carr SA, Waikar SS, Bonventre JV, Ritz J, Stone RM, Steensma DP, Regev A, Glimcher LH. Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias. Nat Immunol. 2021 Nov;22(11):1465. doi: 10.1038/s41590-021-01031-y. PMID: 34522041.
Copy Download .nbib Format: NLM
Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples.

Molecular & cellular proteomics : MCP

Klaeger S, Apffel A, Clauser KR, Sarkizova S, Oliveira G, Rachimi S, Le PM, Tarren A, Chea V, Abelin JG, Braun DA, Ott PA, Keshishian H, Hacohen N, Keskin DB, Wu CJ, Carr SA.
PMID: 34391888
Mol Cell Proteomics. 2021;20:100133. doi: 10.1016/j.mcpro.2021.100133. Epub 2021 Aug 12.

MS is the most effective method to directly identify peptides presented on human leukocyte antigen (HLA) molecules. However, current standard approaches often use 500 million or more cells as input to achieve high coverage of the immunopeptidome, and therefore,...

Cite
Klaeger S, Apffel A, Clauser KR, et al. Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples. Mol Cell Proteomics. 2021;20:100133doi: 10.1016/j.mcpro.2021.100133.
Klaeger, S., Apffel, A., Clauser, K. R., Sarkizova, S., Oliveira, G., Rachimi, S., Le, P. M., Tarren, A., Chea, V., Abelin, J. G., Braun, D. A., Ott, P. A., Keshishian, H., Hacohen, N., Keskin, D. B., Wu, C. J., & Carr, S. A. (2021). Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples. Molecular & cellular proteomics : MCP, 20100133. https://doi.org/10.1016/j.mcpro.2021.100133
Klaeger, Susan, et al. "Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples." Molecular & cellular proteomics : MCP vol. 20 (2021): 100133. doi: https://doi.org/10.1016/j.mcpro.2021.100133
Klaeger S, Apffel A, Clauser KR, Sarkizova S, Oliveira G, Rachimi S, Le PM, Tarren A, Chea V, Abelin JG, Braun DA, Ott PA, Keshishian H, Hacohen N, Keskin DB, Wu CJ, Carr SA. Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples. Mol Cell Proteomics. 2021;20:100133. doi: 10.1016/j.mcpro.2021.100133. Epub 2021 Aug 12. PMID: 34391888; PMCID: PMC8724927.
Copy Download .nbib Format: NLM
Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer.

Nature biotechnology

Ouspenskaia T, Law T, Clauser KR, Klaeger S, Sarkizova S, Aguet F, Li B, Christian E, Knisbacher BA, Le PM, Hartigan CR, Keshishian H, Apffel A, Oliveira G, Zhang W, Chen S, Chow YT, Ji Z, Jungreis I, Shukla SA, Justesen S, Bachireddy P, Kellis M, Getz G, Hacohen N, Keskin DB, Carr SA, Wu CJ, Regev A.
PMID: 34663921
Nat Biotechnol. 2021 Oct 18; doi: 10.1038/s41587-021-01021-3. Epub 2021 Oct 18.

Tumor-associated epitopes presented on MHC-I that can activate the immune system against cancer cells are typically identified from annotated protein-coding regions of the genome, but whether peptides originating from novel or unannotated open reading frames (nuORFs) can contribute to...

Cite
Ouspenskaia T, Law T, Clauser KR, et al. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nat Biotechnol. 2021;doi: 10.1038/s41587-021-01021-3.
Ouspenskaia, T., Law, T., Clauser, K. R., Klaeger, S., Sarkizova, S., Aguet, F., Li, B., Christian, E., Knisbacher, B. A., Le, P. M., Hartigan, C. R., Keshishian, H., Apffel, A., Oliveira, G., Zhang, W., Chen, S., Chow, Y. T., Ji, Z., Jungreis, I., Shukla, S. A., Justesen, S., Bachireddy, P., Kellis, M., Getz, G., Hacohen, N., Keskin, D. B., Carr, S. A., Wu, C. J., & Regev, A. (2021). Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nature biotechnology, . https://doi.org/10.1038/s41587-021-01021-3
Ouspenskaia, Tamara, et al. "Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer." Nature biotechnology vol. (2021). doi: https://doi.org/10.1038/s41587-021-01021-3
Ouspenskaia T, Law T, Clauser KR, Klaeger S, Sarkizova S, Aguet F, Li B, Christian E, Knisbacher BA, Le PM, Hartigan CR, Keshishian H, Apffel A, Oliveira G, Zhang W, Chen S, Chow YT, Ji Z, Jungreis I, Shukla SA, Justesen S, Bachireddy P, Kellis M, Getz G, Hacohen N, Keskin DB, Carr SA, Wu CJ, Regev A. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nat Biotechnol. 2021 Oct 18; doi: 10.1038/s41587-021-01021-3. Epub 2021 Oct 18. PMID: 34663921.
Copy Download .nbib Format: NLM
Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias.

Nature immunology

Raundhal M, Ghosh S, Myers SA, Cuoco MS, Singer M, Carr SA, Waikar SS, Bonventre JV, Ritz J, Stone RM, Steensma DP, Regev A, Glimcher LH.
PMID: 34522041
Nat Immunol. 2021 Nov;22(11):1465. doi: 10.1038/s41590-021-01031-y.

No abstract available.

Cite
Raundhal M, Ghosh S, Myers SA, et al. Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias. Nat Immunol. 2021;22(11):1465doi: 10.1038/s41590-021-01031-y.
Raundhal, M., Ghosh, S., Myers, S. A., Cuoco, M. S., Singer, M., Carr, S. A., Waikar, S. S., Bonventre, J. V., Ritz, J., Stone, R. M., Steensma, D. P., Regev, A., & Glimcher, L. H. (2021). Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias. Nature immunology, 22(11), 1465. https://doi.org/10.1038/s41590-021-01031-y
Raundhal, Mahesh, et al. "Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias." Nature immunology vol. 22,11 (2021): 1465. doi: https://doi.org/10.1038/s41590-021-01031-y
Raundhal M, Ghosh S, Myers SA, Cuoco MS, Singer M, Carr SA, Waikar SS, Bonventre JV, Ritz J, Stone RM, Steensma DP, Regev A, Glimcher LH. Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias. Nat Immunol. 2021 Nov;22(11):1465. doi: 10.1038/s41590-021-01031-y. PMID: 34522041.
Copy Download .nbib Format: NLM
Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides.

Molecular & cellular proteomics : MCP

Burt RA, Dejanovic B, Peckham HJ, Lee KA, Li X, Ounadjela JR, Rao A, Malaker SA, Carr SA, Myers SA.
PMID: 34678516
Mol Cell Proteomics. 2021 Oct 20;20:100167. doi: 10.1016/j.mcpro.2021.100167. Epub 2021 Oct 20.

Antibodies against posttranslational modifications (PTMs) such as lysine acetylation, ubiquitin remnants, or phosphotyrosine have resulted in significant advances in our understanding of the fundamental roles of these PTMs in biology. However, the roles of a number of PTMs remain...

Cite
Burt RA, Dejanovic B, Peckham HJ, et al. Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides. Mol Cell Proteomics. 2021;20:100167doi: 10.1016/j.mcpro.2021.100167.
Burt, R. A., Dejanovic, B., Peckham, H. J., Lee, K. A., Li, X., Ounadjela, J. R., Rao, A., Malaker, S. A., Carr, S. A., & Myers, S. A. (2021). Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides. Molecular & cellular proteomics : MCP, 20100167. https://doi.org/10.1016/j.mcpro.2021.100167
Burt, Rajan A, et al. "Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides." Molecular & cellular proteomics : MCP vol. 20 (2021): 100167. doi: https://doi.org/10.1016/j.mcpro.2021.100167
Burt RA, Dejanovic B, Peckham HJ, Lee KA, Li X, Ounadjela JR, Rao A, Malaker SA, Carr SA, Myers SA. Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides. Mol Cell Proteomics. 2021 Oct 20;20:100167. doi: 10.1016/j.mcpro.2021.100167. Epub 2021 Oct 20. PMID: 34678516; PMCID: PMC8605273.
Copy Download .nbib Format: NLM
Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1.

Science signaling

Lo A, Holmes K, Kamlapurkar S, Mundt F, Moorthi S, Fung I, Fereshetian S, Watson J, Carr SA, Mertins P, Berger AH.
PMID: 34846918
Sci Signal. 2021 Nov 30;14(711):eabc4520. doi: 10.1126/scisignal.abc4520. Epub 2021 Nov 30.

[Figure: see text].

Cite
Lo A, Holmes K, Kamlapurkar S, et al. Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1. Sci Signal. 2021;14(711):eabc4520doi: 10.1126/scisignal.abc4520.
Lo, A., Holmes, K., Kamlapurkar, S., Mundt, F., Moorthi, S., Fung, I., Fereshetian, S., Watson, J., Carr, S. A., Mertins, P., & Berger, A. H. (2021). Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1. Science signaling, 14(711), eabc4520. https://doi.org/10.1126/scisignal.abc4520
Lo, April, et al. "Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1." Science signaling vol. 14,711 (2021): eabc4520. doi: https://doi.org/10.1126/scisignal.abc4520
Lo A, Holmes K, Kamlapurkar S, Mundt F, Moorthi S, Fung I, Fereshetian S, Watson J, Carr SA, Mertins P, Berger AH. Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1. Sci Signal. 2021 Nov 30;14(711):eabc4520. doi: 10.1126/scisignal.abc4520. Epub 2021 Nov 30. PMID: 34846918.
Copy Download .nbib Format: NLM
Proteogenomic characterization of pancreatic ductal adenocarcinoma.

Cell

Cao L, Huang C, Cui Zhou D, Hu Y, Lih TM, Savage SR, Krug K, Clark DJ, Schnaubelt M, Chen L, da Veiga Leprevost F, Eguez RV, Yang W, Pan J, Wen B, Dou Y, Jiang W, Liao Y, Shi Z, Terekhanova NV, Cao S, Lu RJ, Li Y, Liu R, Zhu H, Ronning P, Wu Y, Wyczalkowski MA, Easwaran H, Danilova L, Mer AS, Yoo S, Wang JM, Liu W, Haibe-Kains B, Thiagarajan M, Jewell SD, Hostetter G, Newton CJ, Li QK, Roehrl MH, Fenyö D, Wang P, Nesvizhskii AI, Mani DR, Omenn GS, Boja ES, Mesri M, Robles AI, Rodriguez H, Bathe OF, Chan DW, Hruban RH, Ding L, Zhang B, Zhang H.
PMID: 34534465
Cell. 2021 Sep 16;184(19):5031-5052.e26. doi: 10.1016/j.cell.2021.08.023.

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor patient survival. Toward understanding the underlying molecular alterations that drive PDAC oncogenesis, we conducted comprehensive proteogenomic analysis of 140 pancreatic cancers, 67 normal adjacent tissues, and 9 normal...

Cite
Cao L, Huang C, Cui Zhou D, et al. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell. 2021;184(19):5031-5052.e26doi: 10.1016/j.cell.2021.08.023.
Cao, L., Huang, C., Cui Zhou, D., Hu, Y., Lih, T. M., Savage, S. R., Krug, K., Clark, D. J., Schnaubelt, M., Chen, L., da Veiga Leprevost, F., Eguez, R. V., Yang, W., Pan, J., Wen, B., Dou, Y., Jiang, W., Liao, Y., Shi, Z., Terekhanova, N. V., Cao, S., Lu, R. J., Li, Y., Liu, R., Zhu, H., Ronning, P., Wu, Y., Wyczalkowski, M. A., Easwaran, H., Danilova, L., Mer, A. S., Yoo, S., Wang, J. M., Liu, W., Haibe-Kains, B., Thiagarajan, M., Jewell, S. D., Hostetter, G., Newton, C. J., Li, Q. K., Roehrl, M. H., Fenyö, D., Wang, P., Nesvizhskii, A. I., Mani, D. R., Omenn, G. S., Boja, E. S., Mesri, M., Robles, A. I., Rodriguez, H., Bathe, O. F., Chan, D. W., Hruban, R. H., Ding, L., Zhang, B., Zhang, H. (2021). Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell, 184(19), 5031-5052.e26. https://doi.org/10.1016/j.cell.2021.08.023
Cao, Liwei, et al. "Proteogenomic characterization of pancreatic ductal adenocarcinoma." Cell vol. 184,19 (2021): 5031-5052.e26. doi: https://doi.org/10.1016/j.cell.2021.08.023
Cao L, Huang C, Cui Zhou D, Hu Y, Lih TM, Savage SR, Krug K, Clark DJ, Schnaubelt M, Chen L, da Veiga Leprevost F, Eguez RV, Yang W, Pan J, Wen B, Dou Y, Jiang W, Liao Y, Shi Z, Terekhanova NV, Cao S, Lu RJ, Li Y, Liu R, Zhu H, Ronning P, Wu Y, Wyczalkowski MA, Easwaran H, Danilova L, Mer AS, Yoo S, Wang JM, Liu W, Haibe-Kains B, Thiagarajan M, Jewell SD, Hostetter G, Newton CJ, Li QK, Roehrl MH, Fenyö D, Wang P, Nesvizhskii AI, Mani DR, Omenn GS, Boja ES, Mesri M, Robles AI, Rodriguez H, Bathe OF, Chan DW, Hruban RH, Ding L, Zhang B, Zhang H. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell. 2021 Sep 16;184(19):5031-5052.e26. doi: 10.1016/j.cell.2021.08.023. PMID: 34534465; PMCID: PMC8654574.
Copy Download .nbib Format: NLM
Automating UbiFast for High-throughput and Multiplexed Ubiquitin Enrichment.

Molecular & cellular proteomics : MCP

Rivera KD, Olive ME, Bergstrom EJ, Nelson AJ, Lee KA, Satpathy S, Carr SA, Udeshi ND.
PMID: 34592423
Mol Cell Proteomics. 2021 Sep 27;20:100154. doi: 10.1016/j.mcpro.2021.100154. Epub 2021 Sep 27.

Robust methods for deep-scale enrichment and site-specific identification of ubiquitylation sites are necessary for characterizing the myriad roles of protein ubiquitylation. To this end we previously developed UbiFast, a sensitive method for highly multiplexed ubiquitylation profiling where K-ϵ-GG peptides...

Cite
Rivera KD, Olive ME, Bergstrom EJ, et al. Automating UbiFast for High-throughput and Multiplexed Ubiquitin Enrichment. Mol Cell Proteomics. 2021;20:100154doi: 10.1016/j.mcpro.2021.100154.
Rivera, K. D., Olive, M. E., Bergstrom, E. J., Nelson, A. J., Lee, K. A., Satpathy, S., Carr, S. A., & Udeshi, N. D. (2021). Automating UbiFast for High-throughput and Multiplexed Ubiquitin Enrichment. Molecular & cellular proteomics : MCP, 20100154. https://doi.org/10.1016/j.mcpro.2021.100154
Rivera, Keith D, et al. "Automating UbiFast for High-throughput and Multiplexed Ubiquitin Enrichment." Molecular & cellular proteomics : MCP vol. 20 (2021): 100154. doi: https://doi.org/10.1016/j.mcpro.2021.100154
Rivera KD, Olive ME, Bergstrom EJ, Nelson AJ, Lee KA, Satpathy S, Carr SA, Udeshi ND. Automating UbiFast for High-throughput and Multiplexed Ubiquitin Enrichment. Mol Cell Proteomics. 2021 Sep 27;20:100154. doi: 10.1016/j.mcpro.2021.100154. Epub 2021 Sep 27. PMID: 34592423.
Copy Download .nbib Format: NLM
Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias.

Nature immunology

Raundhal M, Ghosh S, Myers SA, Cuoco MS, Singer M, Carr SA, Waikar SS, Bonventre JV, Ritz J, Stone RM, Steensma DP, Regev A, Glimcher LH.
PMID: 34522041
Nat Immunol. 2021 Nov;22(11):1465. doi: 10.1038/s41590-021-01031-y.

No abstract available.

Cite
Raundhal M, Ghosh S, Myers SA, et al. Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias. Nat Immunol. 2021;22(11):1465doi: 10.1038/s41590-021-01031-y.
Raundhal, M., Ghosh, S., Myers, S. A., Cuoco, M. S., Singer, M., Carr, S. A., Waikar, S. S., Bonventre, J. V., Ritz, J., Stone, R. M., Steensma, D. P., Regev, A., & Glimcher, L. H. (2021). Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias. Nature immunology, 22(11), 1465. https://doi.org/10.1038/s41590-021-01031-y
Raundhal, Mahesh, et al. "Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias." Nature immunology vol. 22,11 (2021): 1465. doi: https://doi.org/10.1038/s41590-021-01031-y
Raundhal M, Ghosh S, Myers SA, Cuoco MS, Singer M, Carr SA, Waikar SS, Bonventre JV, Ritz J, Stone RM, Steensma DP, Regev A, Glimcher LH. Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias. Nat Immunol. 2021 Nov;22(11):1465. doi: 10.1038/s41590-021-01031-y. PMID: 34522041.
Copy Download .nbib Format: NLM
Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1.

Science signaling

Lo A, Holmes K, Kamlapurkar S, Mundt F, Moorthi S, Fung I, Fereshetian S, Watson J, Carr SA, Mertins P, Berger AH.
PMID: 34846918
Sci Signal. 2021 Nov 30;14(711):eabc4520. doi: 10.1126/scisignal.abc4520. Epub 2021 Nov 30.

[Figure: see text].

Cite
Lo A, Holmes K, Kamlapurkar S, et al. Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1. Sci Signal. 2021;14(711):eabc4520doi: 10.1126/scisignal.abc4520.
Lo, A., Holmes, K., Kamlapurkar, S., Mundt, F., Moorthi, S., Fung, I., Fereshetian, S., Watson, J., Carr, S. A., Mertins, P., & Berger, A. H. (2021). Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1. Science signaling, 14(711), eabc4520. https://doi.org/10.1126/scisignal.abc4520
Lo, April, et al. "Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1." Science signaling vol. 14,711 (2021): eabc4520. doi: https://doi.org/10.1126/scisignal.abc4520
Lo A, Holmes K, Kamlapurkar S, Mundt F, Moorthi S, Fung I, Fereshetian S, Watson J, Carr SA, Mertins P, Berger AH. Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1. Sci Signal. 2021 Nov 30;14(711):eabc4520. doi: 10.1126/scisignal.abc4520. Epub 2021 Nov 30. PMID: 34846918.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 29 entries